| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Aug―29 |
Endothelial function and arterial stiffness of patients with cardiovascular diseases hospitalized due to COVID-19 |
C. Araújo, A. Dornelas De Andrade, J. Fernandes, D. Caetano, A.E. Barros, J. Souza, et al. (+5) M.G. Rodrigues-Machado, M.I. Aguiar, S. Brandão, S. Campos, D. Brandão |
| 2 |
[GO] |
2023―Aug―29 |
Endothelial functional status in patients with atherosclerotic coronary artery disease and type 2 diabetes mellitus after COVID-19 |
S. Ubaydullaev, A. Alyavi, J. Uzokov |
| 3 |
[GO] |
2023―Aug―29 |
Indicators of myocardial electrical instability during high-dose atorvastatin therapy in patients after acute myocardial infarction in combination with COVID-19 |
V. Oleynikov, Y. Barmenkova, A. Tonkoglaz, M. Lukyanova, I. Avdeeva |
| 4 |
[GO] |
2023―Aug―29 |
The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19 |
V. Bianconi, M. Mannarino, E. Cosentini, F. Figorilli, C. Colangelo, G. Cellini, et al. (+4) M. Braca, R. Lombardini, R. Paltriccia, M. Pirro |
| 5 |
[GO] |
2023―Aug―29 |
Intracardiac hemodynamics and heart rate variability in stable coronary artery disease patients with concomitant COVID-19 |
V. Netiazhenko, S. Mostovyi, O. Safonova, K. Mikhaliev |
| 6 |
[GO] |
2023―Aug―29 |
Thromboinflammation prevention in COVID-19 hospitalised patients: A retrospective study |
G. Chatzis, M. Vlachopoulou, K. Koronios, E. Stratigaki, D. Fellouri, G. Aleiferis, et al. (+4) P. Koulouris, M. Gasparaki, P. Nikolinakos, S. Bakidis |
| 7 |
[GO] |
2023―Aug―29 |
Effect of polypill therapy on lipid profile and arterial stiffness in patients with dyslipidemia, arterial hypertension and COVID-19 in different age groups |
V. Oleynikov, L. Salyamova, K. Pavlenko, M. Lukyanova, N. Borisova |
| 8 |
[GO] |
2023―Aug―29 |
Low high-density lipoprotein level is a risk factor for postvaccination COVID-19 in hemodialysis patients |
N. Stepanova, A. Rysyev, L. Snisar |
| 9 |
[GO] |
2023―Aug―29 |
Cardiovascular disease (CVD) and COVID-19 infection: A deadly synergism |
J. Hamilton, N. Huang, M. Saeed, M. Sagar, A. Zheng |
| 10 |
[GO] |
2023―Aug―29 |
Effects of COVID-19 severity on the atherosclerotic risk POS-recovery: Relation between inflammation and lipoproteins |
R. Conde, R. Gil-Redondo, M. Bizkarguenaga, C. Bruzzone, A. Laín, B. González-Valle, et al. (+5) L. Egia-Mendikute, N. Embade, A. Palazón, J.M. Mato, Ó. Millet |
| 11 |
[GO] |
2023―Aug―29 |
Characteristics of acute coronary syndrome during COVID 19 pandemic |
L. Ferhatbegovic, B. Pojskic |
| 12 |
[GO] |
2022―Aug―30 |
Cardiovascular outcomes of COVID-19 disease at the elderly |
A. Capisizu, R. Mihalache, A. Capisizu, M. Roman, S.M. Aurelian |
| 13 |
[GO] |
2022―Aug―30 |
Thromboembolic complications in COVID-19 clinical case |
A. Capisizu, S.A. Capisizu, D. Cuzino, A. Zamfirescu |
| 14 |
[GO] |
2022―Aug―30 |
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study |
G. Photiou, N. Middleton, D.B. Panagiotakos, A. Panayiotou |
| 15 |
[GO] |
2022―Aug―30 |
Characteristic of patients with COVID-19 and myocardial infarction |
N.A. Koriagina, V.S. Koriagin, K.V. Prokhorov, G.N. Spasenkov |
| 16 |
[GO] |
2022―Aug―30 |
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence |
A.G. L'Huillier, S. Pagano, S. Baggio, B. Meyer, D.O. Andrey, M. Nehme, et al. (+8) I. Guessous, C.S. Eberhardt, A. Huttner, K.M. Posfay-Barbe, S. Yerly, C.-A. Siegrist, L. Kaiser, N. Vuilleumier |
| 17 |
[GO] |
2022―Aug―30 |
COVID-19 and cardiovascular system: Not only heart but also vascular. The effects of the infection on arterial stiffness |
A. Maloberti, E. Gualini, S. Scarpellini, M. Algeri, M. Biolcati, E. Grasso, et al. (+3) C. Tognola, A. Moreo, C. Giannattasio |
| 18 |
[GO] |
2022―Aug―30 |
Coronary artery disease is an independent risk factor for in-hospital COVID-19 all-cause mortality |
A.V. Shalaeva, K.T. Mirakhmedova, N.A. Dadabaeva, S.S. Egamova, U.S. Abdullaev, A.K. Shadmanov |
| 19 |
[GO] |
2022―Aug―30 |
Flow-mediated dilation of the brachial artery in patients with obesity after COVID-19 |
O. Pogorelova, I.O. Kokaeva, M. Tripoten, Y. Zhernakova, T. Balakhonova |
| 20 |
[GO] |
2022―Aug―30 |
Apolipoproteins A1 level in the plasma of patients with COVID-19 |
L.K. Sokolova, J.B. Belchina, V.M. Pushkarev, O.I. Kovzun, V.V. Pushkarev, M.D. Tronko |
| 21 |
[GO] |
2022―Aug―30 |
Cardiovascular risk factors in patients with primary myocardial infarction in combination with COVID-19 |
V. Oleynikov, L. Salyamova, K. Korenkova, K. Polezhaeva, N. Donetskaya, A. Babina |
| 22 |
[GO] |
2022―Aug―30 |
Features of indicators of central pressure and stiffness in patients with primary myocardial infarction in combination with COVID-19 |
V. Oleynikov, L. Salyamova, M. Lukyanova, K. Korenkova, A. Kulyutsin |
| 23 |
[GO] |
2022―Aug―30 |
The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension |
A. Liontos, D. Biros, A. Papathanasiou, O. Milionis, M. Nasiou, E. Pargana, et al. (+15) N.-G. Kolios, C. Pappa, S. Tsourlos, L. Athanasiou, G. Siopis, A. Zarachi, K. Tsarapatsani, V. Samanidou, R. Konstantopoulou, I. Tsiakas, S. Filippas-Ntekouan, I. Vagias, E. Christaki, E. Liberopoulos, H. Milionis |
| 24 |
[GO] |
2022―Aug―30 |
FT-IR spectroscopic study of atheromatic plaque formation and the risk of COVID-19 mortality of patients with cardiovascular diseases. A mathematical simulation approach |
I. Mamarelis, J. Anastassopoulou, E. Mylonas, V. Mamareli, K. Spiliopoulos, T. Theophanides |
| 25 |
[GO] |
2022―Aug―30 |
Impact of COVID-19 outbreak in stemi patients in the regional emergency center in Seoul, Korea |
Y. Cho, Y. Yoon, S. Park |
| 26 |
[GO] |
2022―Aug―30 |
Adaptation of a new cardiac rehabilitation program in times of COVID-19 pandemic |
M. A. Martin Toro, M. S. Herruzo Rojas, E. J. Martinez De Morentin Laurenz, S. Blasco Turrion, F. J. Morales Ponce |
| 27 |
[GO] |
2022―Aug―30 |
Medical care to patients with acute myocardial infarction during COVID-19 pandemic |
N.A. Koriagina, V.S. Koriagin, K.V. Prokhorov, G.N. Spasenkov |
| 28 |
[GO] |
2022―Aug―30 |
Acute coronary syndrome outside and during the COVID-19 pandemic |
N.A. Koriagina, V.S. Koriagin, A.I. Maltcev, S.G. Shulkina |
| 29 |
[GO] |
2022―Aug―30 |
The management of patients with chronic cardiovascular therapies in Lombardy region: The impact of the COVID-19 pandemic |
F. Galimberti, E. Olmastroni, A.L. Catapano, E. Tragni, M. Casula |
| 30 |
[GO] |
2022―Aug―30 |
New semi-presential modality in cardiac rehabilitation due to COVID-19 pandemic. What results have we obtained? |
M. A. Martin Toro, M. S. Herruzo Rojas, E. J. Martinez De Morentin Laurenz, S. Blasco Turrion, F. J. Morales Ponce |
| 31 |
[GO] |
2022―Aug―30 |
Risk factors of deep vein thrombosis in COVID-19 patients |
M. Tripoten, O. Pogorelova, T. Balakhonova |
| 32 |
[GO] |
2022―Aug―30 |
Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
E.V. Shalaeva, M.I. Shamsutdinova, F.L. Azizova, O.R. Teshaev, S.A. Boymuradov, H. Saner |
| 33 |
[GO] |
2022―Aug―30 |
Significance of LDL-C in appearance of myocardial infarction in COVID-19 patients in Bosnian population - One center experience |
L. (Pojskic) Ferhatbegovic, B. Pojskic, D. Mrsic |
| 34 |
[GO] |
2022―Aug―30 |
Laboratory findings and clinical outcomes of 681 COVID-19 patients with dyslipidemia requiring hospitalization |
A. Liontos, D. Biros, O. Milionis, S. Tsourlos, L. Athanasiou, A. Papathanasiou, et al. (+20) N.-G. Kolios, C. Pappa, C. Veliani, V. Samanidou, G. Siopis, E. Pargana, M. Nasiou, N.-N. Armata, S.-P. Anagnostopoulos, A. Poulopoulou, S. Filippas-Ntekouan, M. Christaki, I. Rapti, A. Panteli, M. Kosmidou, I. Tsiakas, I. Vagias, E. Liberopoulos, E. Christaki, H. Milionis |
| 35 |
[GO] |
2022―Aug―30 |
Thrombotic and thromboembolic events in COVID-19 patients: Association with clinical presentation, progression and laboratory findings. Data analysis of a 681 patient cohort |
A. Liontos, D. Biros, S. Tsourlos, L. Athanasiou, O. Milionis, A. Papathanasiou, et al. (+23) C. Veliani, N.-G. Kolios, C. Pappa, V. Samanidou, G. Siopis, E. Pargana, M. Nasiou, S.-P. Anagnostopoulos, N.-N. Armata, A. Poulopoulou, S. Filippas-Ntekouan, E. Klouras, M. Christaki, I. Rapti, M. Kosmidou, A. Panteli, F. Barkas, G. Papamichael, I. Tsiakas, I. Vagias, E. Liberopoulos, E. Christaki, H. Milionis |
| 36 |
[GO] |
2022―Aug―30 |
Baseline high-density lipoprotein level is associated with COVID-19 pneumonia severity in hemodialysis patients |
N. Stepanova, A. Rysyev, O. Rusyn, T. Ostapenko, L. Snisar, S. Rusanov |
| 37 |
[GO] |
2022―Aug―30 |
Modifiable and non-modifiable cardiovascular risk factors on sensory disorder of smell and taste in COVID-19 population |
A. Liontos, A. Zarachi, O. Milionis, P. Vasileios, I. Komnos, E. Klouras, et al. (+6) A. Lianou, D. Biros, K. Papaloukas, D. Fotiadis, I. Kastanioudakis, H. Milionis |
| 38 |
[GO] |
2022―Aug―30 |
Association of cardiovascular risk factors and olfactory or taste dysfunction in COVID-19 population. Data from an academic center in Greece |
A. Liontos, A. Zarachi, O. Milionis, P. Vasileios, I. Komnos, A. Lianou, et al. (+6) E. Klouras, D. Biros, K. Papaloukas, D. Fotiadis, I. Kastanioudakis, H. Milionis |
| 39 |
[GO] |
2022―Aug―30 |
Coronary atherosclerosis in COVID-19 survivors: Association with cardiac injury and function at 6 weeks |
R.A. Groen, M.A. De Graaf, W.J. Jukema, M.J. Schalij, J.L. Stöger, J.J.M. Geelhoed, M.L. Antoni |
| 40 |
[GO] |
2022―Aug―30 |
COVID-19 vaccination associated severe immune thrombocytopenia: A case report |
M. Mousdi, S. Pegka, M. Skouteli, K. Trachana, G. Chatzis, S. Bakidis |
| 41 |
[GO] |
2022―Aug―30 |
Relationship between biomarkers and global myocardial strain parameters in patients with cardiovascular pathology and metabolic disorders after COVID-19-associated pneumonia |
T. Petelina, N. Musikhina, E. Yaroslavskaya, E. Gorbatenko, N. Galeeva, K. Avdeeva, et al. (+2) A. Shcherbinina, L. Gapon |
| 42 |
[GO] |
2022―Aug―30 |
Coronavirus at the heart center of Puerto Rico incidence-death: The role of genetics |
C.M. Diaz, L.E. Barreto, P.I. Altieri, H.L. Banchs, N. Villar, F.J. Colón |
| 43 |
[GO] |
2022―Aug―30 |
Maternal fructose intake reinforces the effects of a Western-type diet in promoting SARS-CoV-2 cell entry factors in male offspring |
C. Donis, E. Fauste, M. Pérez, L. Rodríguez, S. Rodrigo, J.J. Álvarez-Millán, et al. (+3) P. Otero, M.I. Panadero, C. Bocos |
| 44 |
[GO] |
2022―Aug―30 |
Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
A. Maloberti, C. Giannattasio, P. Rebora, G. Occhino, N. Ughi, J. Rizzo, et al. (+11) S. Fabbri, F. Leidi, I. Cartella, M. Algeri, S. Scarpellini, C. Rossetti, O.M. Epis, G. Molon, P. Bonfanti, M.G. Valsecchi, S. Genovesi |
| 45 |
[GO] |
2022―Aug―30 |
Lipoprotein(a) and SARS-CoV-2 infections: Risk for ischemic heart disease and thromboembolic events |
S. Di Maio, C. Lamina, S. Coassin, L. Forer, R. Würzner, S. Schönherr, F. Kronenberg |
| 46 |
[GO] |
2022―Aug―30 |
Direct and indirect effects of SARS-CoV-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation |
R. Scicali, V. Ferrara, S. Piro, F. Purrello, A. Di Pino |
| 47 |
[GO] |
2022―Aug―30 |
A mouse model of arterial endothelial cell-specific inflammation reveals pathways of endothelial dysfunction and the simultaneous upregulation of ACE2, the receptor of SARS-CoV2 |
J.A. Schmid, M. Mussbacher, J. Basílio, M. Salzmann |
| 48 |
[GO] |
2022―Aug―02 |
Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality |
Morten Kaltoft, Kathrine Glavind, Sune Fallgaard Nielsen, Anne Langsted, Kasper Karmark Iversen, Børge Grønne Nordestgaard, Pia Rørbæk Kamstrup |
| 49 |
[GO] |
2022―Mrz―12 |
Lipoprotein(a) in COVID-19: Genetics and inflammation collide |
Martina Montagnana, Giuseppe Lippi |
| 50 |
[GO] |
2021―Dez―22 |
Pre-infection HDL-cholesterol levels and mortality among elderly patients infected with SARS-CoV-2 |
Jose M. Mostaza, Miguel A. Salinero-Fort, Juan Cardenas-Valladolid, Fernando Rodriguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, et al. (+3) F.Javier San Andres-Rebollo, Ignacio Vicente, Carlos Lahoz |
| 51 |
[GO] |
2021―Dez―21 |
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study |
Nick S. Nurmohamed, Didier Collard, Laurens F. Reeskamp, Yannick Kaiser, Jeffrey Kroon, Tycho R. Tromp, et al. (+9) Bert-Jan H. van den Born, Michiel Coppens, Alexander P.J. Vlaar, Martijn Beudel, Diederik van de Beek, Nick van Es, Patrick M. Moriarty, Sotirios Tsimikas, Erik S.G. Stroes |
| 52 |
[GO] |
2021―Nov―13 |
Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality |
Michael Feher, Mark Joy, Neil Munro, William Hinton, John Williams, Simon de Lusignan |
| 53 |
[GO] |
2021―Sep―15 |
Reply to: “Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead” |
Monica Verdoia, Giuseppe De Luca |
| 54 |
[GO] |
2021―Sep―03 |
Dynamic of lipoprotein responses in patients with severe COVID-19 |
A. Leonard, A. Doolan, G. Boran, D. Burke, T. Moulton, M. Donnelly, et al. (+2) C. Power, A. Rakovac |
| 55 |
[GO] |
2021―Sep―03 |
Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19 |
O. Ahmed, A.K. Mukarram, C. Pirazzini, E. Elena Marasco, M. Pedrelli, M.E. Minniti, et al. (+8) U. Gustafsson, C. Pramfalk, C.J. Binder, E. Petrillo, P. Paolo Garagnani, C.O. Daub, M. Eriksson, P. Parini |
| 56 |
[GO] |
2021―Sep―03 |
Patients with symptomatic coronary artery disease are at the increased risk of worsening the course of the disease after recovery from COVID-19 |
A.V. Shalaeva, K.T. Mirakhmedova, A.K. Shadmanov |
| 57 |
[GO] |
2021―Sep―03 |
SARS-COV-2 (COVID-19) anosmia in patients with obesity: A retrospective study |
N. Sarantis, M. Vlachopoulou, G. Chatzis |
| 58 |
[GO] |
2021―Sep―03 |
Retrospective study of patients admitted form March to January 2021 by COVID-19 in hospital Infanta Elena (Huelva). |
M.E. Mansilla Rodríguez, A. Fulgencio Delgado, G. Mariscal Vázquez, J.I. Ramos Clemente Romero |
| 59 |
[GO] |
2021―Sep―03 |
presentation of SARS-CoV-2 (COVID-19 in patients with congestive heart failure. A Retrospective study |
G. Chatzis, M. Vlachopoulou, A.E. Gawish, A.A.A. Alslmy, M.A. Karish, N.K. Aljarbaa, et al. (+10) M.N. Al Harbi, M.O.N. Alnawmasi, A.N.D. Almansori, R.Z.M. Aldogeman, W. Alshuagfun, O.B. Suleiman, M.N.S. Alsairra, A.S.I. Alshudokhi, A.A.E. Almofadhli, O.A.S. Alnafel |
| 60 |
[GO] |
2021―Sep―03 |
Can plasma lipid levels be correlated to severe COVID-19 infection? |
O.A. Uyaroğlu, M. Özdede, N. Çalık Başaran, B. Köylü, T.K. Şahin, L. Özışık, et al. (+2) M. Durusu Tanrıöver, G. Sain Güven |
| 61 |
[GO] |
2021―Sep―03 |
COVID-19 pandemic and triggered acute myocardial infarction and out-of-hospital cardiac arrest in non-infected individuals |
A. Hammoudeh, E. Mdanat, R. Almoheisen, M. Jabari, H. Janabi, R. Ibdah |
| 62 |
[GO] |
2021―Sep―03 |
How the way we live will look different in the wake of the COVID-19 pandemic? A survey in Greece |
D.B. Panagiotakos, R. Kosti, C. Vassou, C. Pitsavos |
| 63 |
[GO] |
2021―Sep―03 |
COVID-19-related quarantine effect on dietary habits in a northern italian rural population: Data from the BRISIGHELLA heart study |
A.F.G. Cicero, F. Fogacci, M. Giovannini, M. Mezzadri, E. Grandi, C. Borghi |
| 64 |
[GO] |
2021―Sep―03 |
Statin therapy and COVID-19: A retrospective cohort study in a province of Northern Italy |
S. Greco, F. Luciani, E. Giorgini, A. D'Amuri, M. Lopreiato, V. Fortunato, et al. (+4) A. Scopa, G. Vestita, E. Capatti, A. Passaro |
| 65 |
[GO] |
2021―Sep―03 |
Diabetes and overweight/obesity are independent, non-additive, risk factors for the in-hospital severity of COVID-19: An international, multi-center retrospective analysis |
D.K. Longmore, J.E. Miller, S. Bekkering, C. Saner, E. Mifsud, Y. Zhu, et al. (+5) R. Saffery, A. Nichol, G. Colditz, K. Short, D.P. Burgner |
| 66 |
[GO] |
2021―Sep―03 |
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection. |
I. Rossi, D. D'Ardes, B. Bucciarelli, M. Allegra, M.T. Guagnano, F. Santilli, et al. (+5) F. Bianco, M. Marchioni, M. Di Nicola, F. Cipollone, M. Bucci |
| 67 |
[GO] |
2021―Sep―03 |
Development features of coronavirus disease complications in patients with coronary heart disease |
N.M. Nurillaeva, M.M. Makhkamova, K.B. Omarov |
| 68 |
[GO] |
2021―Sep―03 |
Creation of a transgenic mouse model to study the SARS-CoV-2 effect on the pathogenesis of atherosclerosis |
M. Kubekina, L. Ilchuk, A. Bruter, A. Deykin |
| 69 |
[GO] |
2021―Sep―03 |
Acute myocardial infarction after laboratory confirmed SARS-CoV-2 infection |
J. Ena, M. Bou-Collado, M.D. Reyes-Jara, R. Afonso-Carrillo, R. Mulet, V. Valls |
| 70 |
[GO] |
2021―Sep―03 |
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 |
S. Pagano, S. Yery, B. Meyer, C. Juillard, N. Suh, C. Le Terrier, et al. (+15) J.-P. Daguer, F.-S. Lluc, S. Barluenga, G. Piumatti, O. Hartley, B. Lemaitre, C.S. Eberhardt, C.-A. Siegrist, I. Eckerle, S. Stringhini, I. Guessous, L. Kaiser, J. Pugin, N. Winssinger, N. Vuilleumier |
| 71 |
[GO] |
2021―Sep―03 |
How controlled were dyslipidemias in a year of pandemic? |
E.M.M. Silva, B. Marques, C. Cunha, R. Ferreira, C. Bello, C. Limbert, et al. (+2) J. Azinheira, S. Duarte |
| 72 |
[GO] |
2021―Aug―12 |
Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead |
Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon |
| 73 |
[GO] |
2021―Jul―21 |
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry |
Giuseppe De Luca, Niels Debel, Miha Cercek, Lisette Okkels Jensen, Marija Vavlukis, Lucian Calmac, et al. (+75) Tom Johnson, Gerard Rourai Ferrer, Vladimir Ganyukov, Wojtek Wojakowski, Tim Kinnaird, Clemens von Birgelen, Yves Cottin, Alexander IJsselmuiden, Bernardo Tuccillo, Francesco Versaci, Kees-Jan Royaards, Jurrien ten Berg, Mika Laine, Maurits Dirksen, Massimo Siviglia, Gianni Casella, Petr Kala, José Luis Díez Gil, Adrian Banning, Victor Becerra, Ciro De Simone, Andrea Santucci, Xavier Carrillo, Alessandra Scoccia, Giovanni Amoroso, Arnoud WJ. van't Hof, Tomas Kovarnik, Grigorios Tsigkas, Julinda Mehilli, Gabriele Gabrielli, Xacobe Flores Rios, Nikola Bakraceski, Sébastien Levesque, Giuseppe Cirrincione, Vincenzo Guiducci, Michał Kidawa, Leonardo Spedicato, Lucia Marinucci, Peter Ludman, Filippo Zilio, Gennaro Galasso, Enrico Fabris, Maurizio Menichelli, Arturo Garcia-Touchard, Stephane Manzo, Gianluca Caiazzo, Jose Moreu, Juan Sanchis Forés, Luca Donazzan, Luigi Vignali, Rui Teles, Edouard Benit, Pierfrancesco Agostoni, Francisco Bosa Ojeda, Heidi Lehtola, Santiago Camacho-Freiere, Adriaan Kraaijeveld, Ylitalo Antti, Marco Boccalatte, Pierre Deharo, Iñigo Lozano Martínez-Luengas, Bruno Scheller, Efthymia Varytimiadi, Raul Moreno, Giuseppe Uccello, Benjamin Faurie, Alejandro Gutierrez Barrios, Marek Milewski, Ewout Bruwiere, Pieter Smits, Bor Wilbert, Fortunato Scotto Di Uccio, Guido Parodi, Elvin Kedhi, Monica Verdoia |
| 74 |
[GO] |
2021―Jun―25 |
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis |
Anastasios Kollias, Konstantinos G. Kyriakoulis, Ioannis G. Kyriakoulis, Thomas Nitsotolis, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos |
| 75 |
[GO] |
2021―Mai―27 |
Teaching an old dog new tricks: The prognostic role of CACS in hospitalized COVID-19 patients |
Ahmed Ibrahim Ahmed, Paolo Raggi, Mouaz H. Al-Mallah |
| 76 |
[GO] |
2021―Apr―17 |
The prognostic role of cardiac troponin in hospitalized COVID-19 patients |
Ibrahim Halil Tanboğa, Uğur Canpolat, Elif Hande Özcan Çetin, Harun Kundi, Sema Turan, Osman Celik, et al. (+5) Naim Ata, Serkan Çay, Özcan Özeke, Cihangir Kaymaz, Serkan Topaloğlu |
| 77 |
[GO] |
2021―Apr―07 |
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 |
Alessandra Scoccia, Guglielmo Gallone, Alberto Cereda, Anna Palmisano, Davide Vignale, Riccardo Leone, et al. (+32) Valeria Nicoletti, Chiara Gnasso, Alberto Monello, Arif Khokhar, Alessandro Sticchi, Andrea Biagi, Carlo Tacchetti, Francesco Ponticelli, Gian Battista Danzi, Marco Loffi, Gianluca Pontone, Daniele Andreini, Gianni Casella, Gianmarco Iannopollo, Davide Ippolito, Giacomo Bellani, Gianluigi Patelli, Francesca Besana, Claudia Costa, Luigi Vignali, Giorgio Benatti, Mario Iannaccone, Paolo Giacomo Vaudano, Alberto Pacielli, Caterina Chiara De Carlini, Stefano Maggiolini, Pietro Andrea Bonaffini, Michele Senni, Elisa Scarnecchia, Fabio Anastasio, Francesco Giannini, Marco Toselli |
| 78 |
[GO] |
2021―Feb―15 |
Coronavirus disease-19: The multi-level, multi-faceted vasculopathy |
Thiago Quinaglia, Mahsima Shabani, Ikaro Breder, Harry A. Silber, João A.C. Lima, Andrei C. Sposito |
| 79 |
[GO] |
2021―Jan―24 |
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment |
Alpo Vuorio, Frederick Raal, Markku Kaste, Petri T. Kovanen |
| 80 |
[GO] |
2020―Dez―23 |
Patient referrals audit: Evaluation of local cardiovascular risk clinic referrals to help aid patient triage during COVID-19 |
A.H. Boal, C.M. Ross |
| 81 |
[GO] |
2020―Dez―23 |
Obesity is a major risk factor for severe COVID-19 illness |
H.L. Li, B.M. Cheung |
| 82 |
[GO] |
2020―Okt―14 |
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications |
Matthias P. Nägele, Bernhard Haubner, Felix C. Tanner, Frank Ruschitzka, Andreas J. Flammer |
| 83 |
[GO] |
2020―Sep―15 |
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK |
Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, et al. (+15) Alan Rees, Rani Khatib, Jaimini Cegla, Christopher Byrne, Nadeem Qureshi, Nigel Capps, Gordon Ferns, Jules Payne, Jonathan Schofield, Kirsty Nicholson, Dev Datta, Alison Pottle, Julian Halcox, Paul Durrington, Handrean Soran |
| 84 |
[GO] |
2020―Jun―16 |
Management of acute myocardial injury in patients with confirmed or suspected COVID-19 |
Yiannis S. Chatzizisis, Ganesh Gajanan, Deepak L. Bhatt, George Dangas, Thomas Porter |
| 85 |
[GO] |
2020―Mai―28 |
SARS-CoV-2 as a protective factor for cardiovascular mortality? |
Frédéric Dutheil, Marion Trousselard, Valentin Navel |
|
